AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Snipd AI
A deep dive into the emergence of knockoff versions of popular weight loss drugs like Ozempic, Wegovy, and Zepbound. The podcast discusses the risks associated with these unapproved drugs from compounding pharmacies, the influence of social media influencers in promoting them, and the concerns around safety and regulation compared to FDA-approved medications.
Read more
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Compounded weight loss drugs lack FDA approval, raising safety concerns.
- Compounding pharmacies face challenges in ensuring drug safety and quality for consumers.
Deep dives
The Rise of Compounding Pharmacies in the $1 Billion Weight Loss Drug Industry
The podcast discusses the increasing demand for weight loss drugs like Ozempic, Wagovi, and Monjaro, leading to a $1 billion shadow industry. Compounding pharmacies provide these drugs when mainstream pharmacies face shortages. These compounds may not always be approved by the FDA, raising concerns about safety and consistency. Patients often turn to telehealth companies promoting cheaper versions, leading to uncertainties about the drug's authenticity and effectiveness.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode